CL

Colgate-Palmolive CoNYSE CL Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

84.805

Mega

Exchange

XNYS - New York Stock Exchange, Inc

CL Stock Analysis

CL

Neutral

Based on Eyestock quantitative analysis, CL`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

78/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

8.9 %

Undervalued

Market cap $B

84.805

Dividend yield

2.45 %

Shares outstanding

830.38 B

Colgate-Palmolive Co. is engaged in the manufacturing and distribution of consumer products. The company is headquartered in New York City, New York and currently employs 33,800 full-time employees. The firm operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Through Hill's Pet Nutrition, it is also engaged in the pet nutrition market, selling products principally through authorized pet supply retailers, veterinarians, and e-commerce retailers. The company also sells certain of its products direct-to-consumer. The company sells its toothpastes under brands, such as Colgate, Darlie, elmex, hello, meridol, Sorriso and Tom's of Maine; its toothbrushes under brands, such as Colgate, Darlie, elmex and meridol; and its mouthwashes under brands, such as Colgate, elmex and meridol.

View Section: Eyestock Rating